Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/12339Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Saxena, Sanjai | - |
| dc.contributor.author | Kumar, Devendra | - |
| dc.date.accessioned | 2011-07-13T06:51:12Z | - |
| dc.date.available | 2011-07-13T06:51:12Z | - |
| dc.date.issued | 2002-06 | - |
| dc.identifier.issn | 0975-1092 (Online); 0972-592X (Print) | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/12339 | - |
| dc.description | 18-25 | en_US |
| dc.description.abstract | The nature remains as the potential source of organic structures of unparalleled diversity.Successful drug discovery process is often a function of the diversity of chemotypes examined, and therefore, drug discovery programs must aim to evaluate broadest diversity of chemical classes from natural resources in minimum samples and least time. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | NISCAIR-CSIR, India | en_US |
| dc.rights |  CC Attribution-Noncommercial-No Derivative Works 2.5 India | en_US |
| dc.source | NPR Vol.1(3) [May-June 2002] | en_US |
| dc.title | Tailoring Biodiversity for Development of New Therapeutics | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | NPR Vol.1(3) [May-June 2002] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| NPR 1(3) 18-25.pdf | 1.96 MB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.